Skip to main content

Find Clinical Trials

Home
Conditions
Bioequivalence

Clinical trial condition

Bioequivalence

Explore clinical trials studying Bioequivalence. Study availability and eligibility vary by location and protocol.

140 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Bioequivalence trial results

Completed

Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France

NCT03621072

Conditions: Bioequivalence
Locations: Wuxi People's Hospital//Phase One Unit Wuxi, Jiangsu, China

View Trial Details

Completed

Diflucan Bioequivalence Study For Transferring The Manufacture

NCT03821480

Conditions: Bioequivalence
Locations: Chungnam National University Hospital, Clinical Trials Center Daejeon, South Korea

View Trial Details

Completed

Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding Conditions

NCT04751318

Conditions: Bioequivalence
Locations: Innolab Santiago, Chile

View Trial Details

Completed

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

NCT04713904

Conditions: Bioequivalence
Locations: Innolab Santiago, Chile

View Trial Details

Completed

Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions

NCT04723238

Conditions: Bioequivalence
Locations: Innolab Santiago, Chile

View Trial Details

Completed

An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers

NCT04386122

Conditions: Bioequivalence
Locations: Centre of Clinical Pharmacology, Hanoi Medical University Hanoi, Vietnam

View Trial Details

Completed

A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

NCT04466176

Conditions: Bioequivalence
Locations: BECRO Clinical Facility Larissa, Thessaly, Greece

View Trial Details

Completed

A Pilot Bioequivalence Study Between Fluticasone Propionate 500 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 500/50 Inhalation Powder/GSK in Healthy Volunteers

NCT04546256

Conditions: Bioequivalence
Locations: BECRO Clinical Facility Larissa, Thessaly, Greece

View Trial Details

Completed

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

NCT04194905

Conditions: Bioequivalence
Locations: Innolab Santiago, Chile

View Trial Details

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

NCT04230070

Conditions: Bioequivalence
Locations: Innolab Santiago, Chile

View Trial Details